title: Current practice and future perspectives in the treatment of short bowel syndrome in children--a systematic review.
abstract: OBJECTIVE
  Short bowel syndrome (SBS) is a malabsorption disorder of the intestine, which leads to an inadequate alimentary supply. A number of therapeutic approaches are already in use, but research advances may provide new options in the future. The purpose of this paper was to provide an overview of the established therapeutic approaches together with a discussion of the future perspectives in the treatment of patients with SBS. We review those studies dealing with the treatment of SBS patients and discuss both surgical and non-surgical approaches together with tissue engineering.
  
  
  METHODS
  A systemic review of Medline-cited studies dealing with current practice and future perspectives in the treatment of short bowel in children was performed.
  
  
  RESULTS
  Surgical approaches, non-surgical approaches, and tissue engineering which was used in the treatment of SBS were analyzed. Among the surgical approaches, the bowel lengthening procedures and small bowel transplantation are prevalent. Stimulants are most important concerning non-surgical approaches. Tissue engineering seems to be more experimental and was also evaluated.
  
  
  CONCLUSIONS
  The treatment of SBS patients remains very complex. It is eminent to find the best therapeutic option for each patient and to individualize and modify the different possible types of applied techniques frequently.
authors: Division of Pediatric Surgery, University Hospital Heidelberg, Im Neuenheimer Feld 110, 69120 Heidelberg, Germany.
authors: S
authors: S
authors: Weih
authors: M
authors: M
authors: Kessler
authors: H
authors: H
authors: Fonouni
authors: M
authors: M
authors: Golriz
authors: M
authors: M
authors: Hafezi
authors: A
authors: A
authors: Mehrabi
authors: S
authors: S
authors: Holland-Cunz
mesh_terms: D002648:Child; D013505:Digestive System Surgical Procedures / Q000379:methods; D016228:Endothelial Growth Factors / Q000627:therapeutic use; D005544:Forecasting; D053767:Glucagon-Like Peptide 2 / Q000627:therapeutic use; D019382:Human Growth Hormone / Q000627:therapeutic use; D006801:Humans; D012778:Short Bowel Syndrome / Q000628:therapy*; D023822:Tissue Engineering
chemical_list: D016228:Endothelial Growth Factors; D053767:Glucagon-Like Peptide 2; D019382:Human Growth Hormone